The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-8.5% to $162.00
Predicted High$176.20in 2 weeks
Predicted Low$160.50at 5 months
Max Drawdown (predicted)-9.4%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 5, 2026 2:41 am
Bear
EFX trends lower to
$162.00
(-8.5% from $177.12)
by Feb 2027.
decay
ThesisEFX sits well above fair value anchors with weak momentum and mild negative sentiment, but a risk-on regime and lack of imminent catalyst limits near-term downside. Path drifts lower as value gravity slowly pulls the stock toward the anchored-PE region, with mean reversion accelerating in months 3-5.
Invalidated ifA decisive break above $190 on volume or a strong earnings beat with raised guidance would invalidate the drift-lower thesis.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $177.12 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 5, 2026
—
$177.12at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 19, 2026
$161.67–$192.57typical range · internal point $176.20
—
±8.7%
6/10
Risk-on tape supports drift, no near catalyst
What actually happened:
closed $194.73
on Aug 19, 2026 = +9.9% vs the call
(predicted -0.5%)
· direction MISS
(called flat, was up)
· off by 10.5 pp
· accuracy 4/10
· typical range ±8.7%:
OUTSIDE the band
· S&P +0.2%
over the same window — lagged it
1 month
Sep 5, 2026
$154.72–$199.52typical range · internal point $174.00
—
±12.6%
5/10
Mild sentiment drag, low-beta grind lower
2 months
Oct 5, 2026
$170.50
—
-3.7%
5/10
Q3 print approaches, positioning tightens
3 months
Nov 5, 2026
$167.00
—
-5.7%
4/10
Earnings reaction fades toward valuation gravity
4 months
Dec 5, 2026
$163.00
—
-8.0%
4/10
Year-end rotation away from richly-priced names
5 months
Jan 5, 2027
$160.50
—
-9.4%
3/10
Value convergence pressure meets baseline endpoint
6 months
Feb 5, 2027
$162.00
—
-8.5%
3/10
Stabilization near baseline, still above fair value
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$162.55
(-8.2%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.